Intended for healthcare professionals


More doctors are disclosing payments from drug companies

BMJ 2017; 357 doi: (Published 30 June 2017) Cite this as: BMJ 2017;357:j3195
  1. Nigel Hawkes
  1. London

Nearly two thirds of doctors and other healthcare professionals in the UK have chosen to disclose the payments made to them by drug companies in 2016, a rise of 10 percentage points from 2015.

But some of those doctors who receive the bigger payments have withheld their names, as they are entitled to do. The 65% who chose to disclose accounted for 60% of the total payments, excluding those for conducting trials.

The industry paid a total of £454.5m (€520m; $590m) to work with healthcare professionals and healthcare organisations in the UK in 2016, the latest data released on the Association of the British Pharmaceutical Industry’s disclosure website show ( …

View Full Text

Log in

Log in through your institution


* For online subscription